Browse by subject

PhD opportunities: Pharmaceutical Chemistry

Compare 5 doctoral research opportunities connected with Pharmaceutical Chemistry, including project summaries, funding and application deadlines.

Pharmaceutical Chemistry

P7) Photochemical arylative carbonylation and formylation using manganese and tandem manganese/palladium catalysis

University of York

About the Project The project will explore the potential of earth abundant metal (EAM) catalysts for arylative carbonylation reactions employing suitable aromatic and heteroaromatic halide / pseudohalide and organoboron coupling partners in the presence of a safe carbon monoxide-releasing surrogate and activator. A successful project will provide a complementary tool to the well-known thermal Pd-catalysed reaction variant.

Location: York, United Kingdom, United Kingdom
Deadline: 13 November 2026
Funding: Competition Funded PhD Project (Students Worldwide)

Pharmaceutical Chemistry

Developing novel formulations and materials for transmucosal drug delivery

University of Reading

About the Project Mucosal routes of drug administration offer numerous advantages including ease of application, non-invasive nature and sometimes possibility of targeting particular organs. We are interested in the development of novel dosage forms and materials for transmucosal routes of drug delivery. Areas of interest include drug delivery to the eye, nose, oral cavity, gastrointestinal tract, urinary bladder, vagina and rectum.

Location: Reading, United Kingdom, United Kingdom
Deadline: Year-round applications
Funding: Self-Funded PhD Students Only

Pharmaceutical Chemistry

Development of a Novel Long Term Composite Dosage Form for Controlled Transmucosal Drug Delivery

University of Bradford

About the Project Despite the number of mucoadhesive dosage forms available, the delivery of drugs through the mucosa still presents major challenges such as a lack of drug localization due to their short residence times, difficulties in accurate drug dosing and poor patient compliance.

Location: Bradford, United Kingdom, United Kingdom
Deadline: Year-round applications
Funding: Self-Funded PhD Students Only

Pharmaceutical Chemistry

Discovery of New Treatments for Parkinson’s disease

Cardiff University

About the Project Summary Parkinson’s disease (PD) is the second most common neurological disease in the world. Current PD therapies and medical interventions are very limited and only address the symptoms of this disease highlighting the need for new and effective treatments for this disease. Recently, we discovered a series of small molecules that have the potential to treat Parkinson’s disease.

Location: Cardiff, United Kingdom, United Kingdom
Deadline: Year-round applications
Funding: Self-Funded PhD Students Only

Pharmaceutical Chemistry

Therapeutic resolution of BMPR2-mediated signalling defects in pulmonary arterial hypertension (PAH)

University of Bradford

About the Project Pulmonary arterial hypertension (PAH) is an incurable and devastating disease and death occurs within 2.5 years of diagnosis. Sustained elevation of the pulmonary arterial pressure (PAP) above 25mm Hg at rest or 30mm Hg during exercise with a normal pulmonary capillary wedge pressure (≤15mm Hg) in the absence of underlying heart, lung or thrombo-occlusive disorders is clinically known as PAH. At present, there is no cure for this disorder.

Location: Bradford, United Kingdom, United Kingdom
Deadline: Year-round applications
Funding: Self-Funded PhD Students Only